IN2012DE00728A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DE00728A IN2012DE00728A IN728DE2012A IN2012DE00728A IN 2012DE00728 A IN2012DE00728 A IN 2012DE00728A IN 728DE2012 A IN728DE2012 A IN 728DE2012A IN 2012DE00728 A IN2012DE00728 A IN 2012DE00728A
- Authority
- IN
- India
- Prior art keywords
- solution
- organic solvent
- heating
- imatinib mesylate
- clear solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2012/054240 WO2013136141A1 (en) | 2012-03-13 | 2012-08-22 | An improved process for the preparation of alpha form of imatinib mesylate |
| IN728DE2012 IN2012DE00728A (enExample) | 2012-03-13 | 2012-08-22 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN728DE2012 IN2012DE00728A (enExample) | 2012-03-13 | 2012-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DE00728A true IN2012DE00728A (enExample) | 2015-08-21 |
Family
ID=47010664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN728DE2012 IN2012DE00728A (enExample) | 2012-03-13 | 2012-08-22 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2012DE00728A (enExample) |
| WO (1) | WO2013136141A1 (enExample) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW225528B (enExample) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
| CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| CA2555804C (en) | 2004-02-11 | 2012-06-26 | Natco Pharma Limited | Polymorphic form of imatinib mesylate and a process for its preparation |
| UA84462C2 (ru) | 2004-04-02 | 2008-10-27 | Институт Фармацевтични | Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой |
| TR200701870T1 (tr) | 2004-09-02 | 2007-05-21 | Cipla Limited | İmatinib mesilatın kararlı kristal formu ve bu formun hazırlanması için işlem. |
| WO2006048890A1 (en) | 2004-11-04 | 2006-05-11 | Sun Pharmaceutical Industries Limited | Imatinib mesylate crystal form and process for preparation thereof |
| CA2651353C (en) | 2006-04-27 | 2012-11-13 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form .alpha. |
| US20060223816A1 (en) | 2006-05-08 | 2006-10-05 | Chemagis Ltd. | Imatinib mesylate alpha form and production process therefor |
| US7550591B2 (en) | 2007-05-02 | 2009-06-23 | Chemagis Ltd. | Imatinib production process |
| EP2291366A4 (en) | 2008-05-26 | 2012-06-06 | Reddys Lab Ltd Dr | PREPARATION OF IMATINIB MESYLATE |
| PL215042B1 (pl) * | 2008-08-01 | 2013-10-31 | Temapharm Spolka Z Ograniczona Odpowiedzialnoscia | Sposób wytwarzania imatinibu |
| US20100330130A1 (en) | 2009-05-22 | 2010-12-30 | Actavis Group Ptc Ehf | Substantially pure imatinib or a pharmaceutically acceptable salt thereof |
| WO2011099039A1 (en) | 2010-02-15 | 2011-08-18 | Reliance Life Sciences Pvt. Ltd. | Process for the preparation of alpha form of imatinib mesylate |
| PL390611A1 (pl) | 2010-03-04 | 2011-09-12 | Tomasz Koźluk | Sposób otrzymywania polimorficznej formy alfa i nowa forma polimorficzna mesylanu imatinibu |
| WO2011158255A1 (en) | 2010-06-16 | 2011-12-22 | Aptuit Laurus Private Limited | Process for preparation of stable imatintb mesylate alpha form |
| SI2582689T1 (sl) | 2010-06-18 | 2017-05-31 | Krka, D.D., Novo Mesto | Nova polimorfna oblika imatinib baze in priprava njenih soli |
| CN102190649B (zh) * | 2011-03-28 | 2013-01-02 | 齐鲁天和惠世制药有限公司 | 一种制备α型甲磺酸伊马替尼的方法 |
-
2012
- 2012-08-22 IN IN728DE2012 patent/IN2012DE00728A/en unknown
- 2012-08-22 WO PCT/IB2012/054240 patent/WO2013136141A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013136141A1 (en) | 2013-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ705827A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| ZA202407520B (en) | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use | |
| ECSP18010065A (es) | Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol | |
| NZ734451A (en) | Preparation, uses and solid forms of obeticholic acid | |
| MY167395A (en) | Method for producing glufosinate p free acid | |
| CO6541539A2 (es) | Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas | |
| MD20120129A2 (en) | Process for the preparation of perindopril L-arginine salt | |
| TR201907789T4 (tr) | Kalkobutrol hazirlanişina yöneli̇k yöntem | |
| NZ733225A (en) | Crystalline forms of grapiprant | |
| AR117002A2 (es) | Proceso para la preparación de inhibidores de quinasa c-fms | |
| IN2014DN02166A (enExample) | ||
| IN2014MN02314A (enExample) | ||
| IN2014KN02722A (enExample) | ||
| UY31577A1 (es) | Proceso para la preparacion de 6-sustituido-1-(2h)-isoquinolinonas | |
| NZ603653A (en) | Processes for the preparation of dipyridamole | |
| WO2014125270A8 (en) | Process for preparing atazanavir sulphate | |
| BR112019000291A2 (pt) | processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel | |
| IN2012DE00728A (enExample) | ||
| BR112016024977A2 (pt) | processo para a preparação de polimorfos de imidacloprida | |
| IN2014DN08226A (enExample) | ||
| GEP20156350B (en) | New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid | |
| RU2013122379A (ru) | Способ синтеза дротаверина | |
| MX2010007923A (es) | Forma cristalina de abacavir que esta esencialmente libre de disolvente. | |
| WO2015188243A9 (en) | PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM | |
| IN2013MU03508A (enExample) |